The latest updated of drug registration lists on 07 July 2025.

Close

No Brand Name Ingredients Dosage Form Primary Packaging Indications EDL License Owner Manufacturer Country Activity Reg No. Reg Date Expiry Date Action
2551 VAGIVEX VT6 TABLETS CLOTRIMAZOLE USP 100 MG VAGINAL TABLETS BLISTERPACK TREATMENT OF CANDIDAL VAGINITIS NULL VE PRODUCTS (LAO) CO.,LTD PENTA KRAFT INDIA CERTIFICATE RELEASED 08 I 5599/23 05-SEP-2023 04-SEP-2026 View
2552 VEXER-75 PREGABALIN IH 75 MG CAPSULE ALU-ALU BLISTER FOR THE TREATMENT OF PERIPHERAL AND CENTRAL NEUROPATHIC PAIN IN ADULTS, AS ADJUNCTIVE THERAPY IN ADULTS WITH PARTIAL SEIZURES WITH OR WITHOUT SEONDARY GENERALIZATON, FOR THE TREATMENT OF GENREALISED ANXIETY DISODER IN ADULTS NULL VE PRODUCTS (LAO) CO.,LTD WEST-COAST PHARMACEUTICAL WORKS LTD. INDIA CERTIFICATE RELEASED 01 I 5178/22 16-JAN-2025 15-JAN-2030 View
2553 VEXGID 80 Gliclazide BP 80 mg Tablets Alu-Alu Blister Non-insulin dependent diabetes (type 2) NULL VE PRODUCTS (LAO) CO.,LTD WEST-COAST PHARMACEUTICAL WORKS LTD INDIA CERTIFICATE RELEASED 12 I 5838/24 30-DEC-2024 29-DEC-2029 View
2554 Vexgid MR 30 Gliclazide BP 30 mg Tablets Alu-Alu Blister Non-insulin dependent diabetes (type 2) in adults when dietary measures, physical exercise and weight loss along are not sufficient to control blood glucose. NULL VE PRODUCTS (LAO) CO.,LTD WEST-COAST PHARMACEUTICAL WORKS LTD INDIA CERTIFICATE RELEASED 12 I 5839/24 30-DEC-2024 29-DEC-2029 View
2555 Vexgid MR 60 Gliclazide BP 60 mg Tablets Alu-Alu Blister Non-insulin dependent diabetes (type 2) in adults when dietary measures, physical exercise and weight loss along are not sufficient to control blood glucose. NULL VE PRODUCTS (LAO) CO.,LTD WEST-COAST PHARMACEUTICAL WORKS LTD INDIA CERTIFICATE RELEASED 12 I 5840/24 30-DEC-2024 29-DEC-2029 View
2556 VEXLEV 250 LEVETIRACETAM USP 250 mg Film coated Tablets Alu-Alu Blister Monotherapy of focal seizures with or without secondary generalisation  Adjunctive therapy of focal seizures with or without secondary generalisation  Adjunctive therapy of myoclonic seizures and tonic-clonic seizures NULL VE PRODUCTS (LAO) CO.,LTD 4Care Lifescience Pvt. Ltd. INDIA CERTIFICATE RELEASED 12 I 5841/24 30-DEC-2024 29-DEC-2029 View
2557 VEXLEV 500 LEVETIRACETAM USP 500 mg Film coated Tablets Alu-Alu Blister Monotherapy of focal seizures with or without secondary generalisation  Adjunctive therapy of focal seizures with or without secondary generalisation  Adjunctive therapy of myoclonic seizures and tonic-clonic seizures NULL VE PRODUCTS (LAO) CO.,LTD 4Care Lifescience Pvt. Ltd. INDIA CERTIFICATE RELEASED 12 I 5842/24 30-DEC-2024 29-DEC-2029 View
2558 VEXMET 1000 XR Metformin Hydrochloride USP 1000 mg Film coated Tablets Alu-Alu Blister Treatment of type 2 diabetes mellitus, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control.  In adults, VEXMET may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.  In children from 10 years of age and adolescents, VEXMET may be used as monotherapy or in combination with insulin.  A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure NULL VE PRODUCTS (LAO) CO.,LTD WEST-COAST PHARMACEUTICAL WORKS LTD INDIA CERTIFICATE RELEASED 12 I 5843/24 30-DEC-2024 29-DEC-2029 View
2559 VEXMET 500 Metformin Hydrochloride USP 500 mg Film coated Tablets Alu-Alu Blister Treatment of type 2 diabetes mellitus, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control.  In adults, VEXMET may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.  In children from 10 years of age and adolescents, VEXMET may be used as monotherapy or in combination with insulin.  A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure NULL VE PRODUCTS (LAO) CO.,LTD WEST-COAST PHARMACEUTICAL WORKS LTD INDIA CERTIFICATE RELEASED 12 I 5844/24 30-DEC-2024 29-DEC-2029 View
2560 VEXMET 850 Metformin Hydrochloride USP 850 mg Film coated Tablets Alu-Alu Blister Treatment of type 2 diabetes mellitus, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control.  In adults, VEXMET may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.  In children from 10 years of age and adolescents, VEXMET may be used as monotherapy or in combination with insulin.  A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure NULL VE PRODUCTS (LAO) CO.,LTD WEST-COAST PHARMACEUTICAL WORKS LTD INDIA CERTIFICATE RELEASED 12 I 5845/24 30-DEC-2024 29-DEC-2029 View